{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:45:10Z","timestamp":1791053110893,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1124\/jpet.108.145862","type":"journal-article","created":{"date-parts":[[2009,1,9]],"date-time":"2009-01-09T02:49:29Z","timestamp":1231469369000},"page":"123-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Therapeutic Effect of Blocking CXCR2 on Neutrophil Recruitment and Dextran Sodium Sulfate-Induced Colitis"],"prefix":"10.1016","volume":"329","author":[{"given":"Shukkur Muhammed","family":"Farooq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RoseMarie","family":"Stillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majlis","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Svanborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Strieter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Stadnyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.108.145862_bib1","doi-asserted-by":"crossref","unstructured":"Agace WW, Hedges SR, Ceska M, and Svanborg C (1993) Interleukin-8 and the neutrophil response to mucosal gram-negative infection. J Clin Invest 92: 780-785.","DOI":"10.1172\/JCI116650"},{"key":"10.1124\/jpet.108.145862_bib2","doi-asserted-by":"crossref","unstructured":"Ajuebor MN, Zagorski J, Kunkel SL, Strieter RM, and Hogaboam CM (2004) Contrasting roles for CXCR2 during experimental colitis. Exp Mol Pathol 76: 1-8.","DOI":"10.1016\/j.yexmp.2003.08.004"},{"key":"10.1124\/jpet.108.145862_bib3","doi-asserted-by":"crossref","unstructured":"Belperio JA, Keane MP, Burdick MD, Londhe V, Xue YY, Li K, Phillips RJ, and Strieter RM (2002) Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J Clin Invest 110: 1703-1716.","DOI":"10.1172\/JCI15849"},{"key":"10.1124\/jpet.108.145862_bib4","doi-asserted-by":"crossref","unstructured":"Bento AF, Leite DF, Claudino RF, Hara DB, Leal PC, and Calixto JB (2008) The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice. J Leukoc Biol 84: 1213-1221.","DOI":"10.1189\/jlb.0408231"},{"key":"10.1124\/jpet.108.145862_bib5","doi-asserted-by":"crossref","unstructured":"Borchers MT, Ansay T, DeSalle R, Daugherty BL, Shen H, Metzger M, Lee NA, and Lee JJ (2002) In vitro assessment of chemokine receptor-ligand interactions mediating mouse eosinophil migration. J Leukoc Biol 71: 1033-1041.","DOI":"10.1189\/jlb.71.6.1033"},{"key":"10.1124\/jpet.108.145862_bib6","doi-asserted-by":"crossref","unstructured":"Broaddus VC, Boylan AM, Hoeffel JM, Kim KJ, Sadick M, Chuntharapai A, and H\u00e9bert CA (1994) Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. J Immunol 152: 2960-2967.","DOI":"10.4049\/jimmunol.152.6.2960"},{"key":"10.1124\/jpet.108.145862_bib7","doi-asserted-by":"crossref","unstructured":"Buanne P, Di Carlo E, Caputi L, Brandolini L, Mosca M, Cattani F, Pellegrini L, Biordi L, Coletti G, Sorrentino G, et al. (2007) Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice. J Leukoc Biol 82: 1239-1246.","DOI":"10.1189\/jlb.0207118"},{"key":"10.1124\/jpet.108.145862_bib8","doi-asserted-by":"crossref","unstructured":"Buell MG and Berin MC (1994) Neutrophil-independence of the initiation of colonic injury: comparison of results from three models of experimental colitis in the rat. Dig Dis Sci 39: 2575-2588.","DOI":"10.1007\/BF02087693"},{"key":"10.1124\/jpet.108.145862_bib9","doi-asserted-by":"crossref","unstructured":"Cacalano G, Lee J, Kikly K, Ryan AM, Pitts-Meek S, Hultgren B, Wood WI, and Moore MW (1994) Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 265: 682-684.","DOI":"10.1126\/science.8036519"},{"key":"10.1124\/jpet.108.145862_bib10","doi-asserted-by":"crossref","unstructured":"Costa F, Mumolo MG, Ceccarelli L, Bellini M, Romano MR, Sterpi C, Ricchiuti A, Marchi S, and Bottai M (2005) Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn\u2019s disease. Gut 54: 364-368.","DOI":"10.1136\/gut.2004.043406"},{"key":"10.1124\/jpet.108.145862_bib11","doi-asserted-by":"crossref","unstructured":"Diamanti A, Colistro F, Basso MS, Papadatou B, Francalanci P, Bracci F, Muraca M, Knafelz D, De Angelis P, and Castro M (2008) Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases. Inflamm Bowel Dis 14: 1229-1235.","DOI":"10.1002\/ibd.20472"},{"key":"10.1124\/jpet.108.145862_bib12","doi-asserted-by":"crossref","unstructured":"Echchannaoui H, Frei K, Letiembre M, Strieter RM, Adachi Y, and Landmann R (2005) CD14 deficiency leads to increased MIP-2 production, CXCR2 expression, neutrophil transmigration, and early death in pneumococcal infection. J Leukoc Biol 78: 705-715.","DOI":"10.1189\/jlb.0205063"},{"key":"10.1124\/jpet.108.145862_bib13","doi-asserted-by":"crossref","unstructured":"Frend\u00e9us B, Godaly G, Hang L, Karpman D, Lundstedt AC, and Svanborg C (2000) Interleukin-8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart. J Exp Med 192: 881-890.","DOI":"10.1084\/jem.192.6.881"},{"key":"10.1124\/jpet.108.145862_bib14","doi-asserted-by":"crossref","unstructured":"Godaly G, Bergsten G, Hang L, Fischer H, Frend\u00e9us B, Lundstedt AC, Samuelsson M, Samuelsson P, and Svanborg C (2001) Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J Leukoc Biol 69: 899-906.","DOI":"10.1189\/jlb.69.6.899"},{"key":"10.1124\/jpet.108.145862_bib15","doi-asserted-by":"crossref","unstructured":"Iikura M, Miyamasu M, Yamaguchi M, Kawasaki H, Matsushima K, Kitaura M, Morita Y, Yoshie O, Yamamoto K, and Hirai K (2001) Chemokine receptors in human basophils: inducible expression of functional CXCR4. J Leukoc Biol 70: 113-120.","DOI":"10.1189\/jlb.70.1.113"},{"key":"10.1124\/jpet.108.145862_bib16","doi-asserted-by":"crossref","unstructured":"Inngjerdingen M, Damaj B, and Maghazachi AA (2001) Expression and regulation of chemokine receptors in human natural killer cells. Blood 97: 367-375.","DOI":"10.1182\/blood.V97.2.367"},{"key":"10.1124\/jpet.108.145862_bib17","doi-asserted-by":"crossref","unstructured":"Keane MP, Belperio JA, Xue YY, Burdick MD, and Strieter RM (2004) Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. J Immunol 172: 2853-2860.","DOI":"10.4049\/jimmunol.172.5.2853"},{"key":"10.1124\/jpet.108.145862_bib18","doi-asserted-by":"crossref","unstructured":"Kucharzik T, Hudson JT 3rd, L\u00fcgering A, Abbas JA, Bettini M, Lake JG, Evans ME, Ziegler TR, Merlin D, Madara JL, et al. (2005) Acute induction of human IL-8 production by intestinal epithelium triggers neutrophil infiltration without mucosal injury. Gut 54: 1565-1572.","DOI":"10.1136\/gut.2004.061168"},{"key":"10.1124\/jpet.108.145862_bib19","doi-asserted-by":"crossref","unstructured":"K\u00fchl AA, Kakirman H, Janotta M, Dreher S, Cremer P, Pawlowski NN, Loddenkemper C, Heimesaat MM, Grollich K, Zeitz M, et al. (2007) Aggravation of different types of experimental colitis by depletion or adhesion blockade of neutrophils. Gastroenterology 133: 1882-1892.","DOI":"10.1053\/j.gastro.2007.08.073"},{"key":"10.1124\/jpet.108.145862_bib20","doi-asserted-by":"crossref","unstructured":"Kwon JH, Keates AC, Anton PM, Botero M, Goldsmith JD, and Kelly CP (2005) Topical antisense oligonucleotide therapy against LIX, an enterocyte-expressed CXC chemokine, reduces murine colitis. Am J Physiol Gastrointest Liver Physiol 289: G1075-G1083.","DOI":"10.1152\/ajpgi.00073.2005"},{"key":"10.1124\/jpet.108.145862_bib21","doi-asserted-by":"crossref","unstructured":"Matityahu E, Feniger-Barish R, Meshel T, Zaslaver A, and Ben-Baruch A (2002) Intracellular trafficking of human CXCR1 and CXCR2: regulation by receptor domains and actin-related kinases. Eur J Immunol 32: 3525-3535.","DOI":"10.1002\/1521-4141(200212)32:12<3525::AID-IMMU3525>3.0.CO;2-1"},{"key":"10.1124\/jpet.108.145862_bib22","doi-asserted-by":"crossref","unstructured":"McCormack G, Moriarty D, O\u2019Donoghue DP, McCormick PA, Sheahan K, and Baird AW (2001) Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflamm Res 50: 491-495.","DOI":"10.1007\/PL00000223"},{"key":"10.1124\/jpet.108.145862_bib23","doi-asserted-by":"crossref","unstructured":"Melgar S, Karlsson L, Rehnstr\u00f6m E, Karlsson A, Utkovic H, Jansson L, and Micha\u00eblsson E (2008) Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease. Int Immunopharmacol 8: 836-844.","DOI":"10.1016\/j.intimp.2008.01.036"},{"key":"10.1124\/jpet.108.145862_bib24","doi-asserted-by":"crossref","unstructured":"Moore TA, Newstead MW, Strieter RM, Mehrad B, Beaman BL, and Standiford TJ (2000) Bacterial clearance and survival are dependent on CXC chemokine receptor-2 ligands in a murine model of pulmonary Nocardia asteroides infection. J Immunol 164: 908-915.","DOI":"10.4049\/jimmunol.164.2.908"},{"key":"10.1124\/jpet.108.145862_bib25","doi-asserted-by":"crossref","unstructured":"Morgan SJ, Moore MW, Cacalano G, and Ley K (1997) Reduced leukocyte adhesion response and absence of slow leukocyte rolling in interleukin-8 receptor-deficient mice. Microvasc Res 54: 188-191.","DOI":"10.1006\/mvre.1997.2029"},{"key":"10.1124\/jpet.108.145862_bib26","doi-asserted-by":"crossref","unstructured":"Ness TL, Hogaboam CM, Strieter RM, and Kunkel SL (2003) Immunomodulatory role of CXCR2 during experimental septic peritonitis. J Immunol 171: 3775-3784.","DOI":"10.4049\/jimmunol.171.7.3775"},{"key":"10.1124\/jpet.108.145862_bib27","doi-asserted-by":"crossref","unstructured":"Ohtsuka Y and Sanderson IR (2003) Dextran sulfate sodium-induced inflammation is enhanced by intestinal epithelial cell chemokine expression in mice. Pediatr Res 53: 143-147.","DOI":"10.1203\/00006450-200301000-00024"},{"key":"10.1124\/jpet.108.145862_bib28","doi-asserted-by":"crossref","unstructured":"Reutershan J, Morris MA, Burcin TL, Smith DF, Chang D, Saprito MS, and Ley K (2006) Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung. J Clin Invest 116: 695-702.","DOI":"10.1172\/JCI27009"},{"key":"10.1124\/jpet.108.145862_bib29","doi-asserted-by":"crossref","unstructured":"Sekido N, Mukaida N, Harada A, Nakanishi I, Watanabe Y, and Matsushima K (1993) Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 365: 654-657.","DOI":"10.1038\/365654a0"},{"key":"10.1124\/jpet.108.145862_bib30","doi-asserted-by":"crossref","unstructured":"Stadnyk AW (2002) Intestinal epithelial cells as a source of inflammatory cytokines and chemokines. Can J Gastroenterol 16: 241-246.","DOI":"10.1155\/2002\/941087"},{"key":"10.1124\/jpet.108.145862_bib31","doi-asserted-by":"crossref","unstructured":"Svensson M, Irjala H, Svanborg C, and Godaly G (2008) Effects of epithelial and neutrophil CXCR2 on innate immunity and resistance to kidney infection. Kidney Int 74: 81-90.","DOI":"10.1038\/ki.2008.105"},{"key":"10.1124\/jpet.108.145862_bib32","doi-asserted-by":"crossref","unstructured":"Takata H, Tomiyama H, Fujiwara M, Kobayashi N, and Takiguchi M (2004) Cutting edge: expression of chemokine receptor CXCR1 on human effector CD8+ T cells. J Immunol 173: 2231-2235.","DOI":"10.4049\/jimmunol.173.4.2231"},{"key":"10.1124\/jpet.108.145862_bib33","doi-asserted-by":"crossref","unstructured":"Thomas KM, Taylor L, and Navarro J (1991) The interleukin-8 receptor is encoded by a neutrophil-specific cDNA clone, F3R. J Biol Chem 266: 14839-14841.","DOI":"10.1016\/S0021-9258(18)98547-9"},{"key":"10.1124\/jpet.108.145862_bib34","doi-asserted-by":"crossref","unstructured":"White JR, Lee JM, Young PR, Hertzberg RP, Jurewicz AJ, Chaikin MA, Widdowson K, Foley JJ, Martin LD, Griswold DE, et al. (1998) Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem 273: 10095-10098.","DOI":"10.1074\/jbc.273.17.10095"},{"key":"10.1124\/jpet.108.145862_bib35","doi-asserted-by":"crossref","unstructured":"Z\u2019Graggen K, Walz A, Mazzucchelli L, Strieter RM, and Mueller C (1997) The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease. Gastroenterology 113: 808-816.","DOI":"10.1016\/S0016-5085(97)70175-6"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524383387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524383387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.108.145862","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:04:36Z","timestamp":1744149876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524383387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0022356524383387"],"URL":"https:\/\/doi.org\/10.1124\/jpet.108.145862","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Effect of Blocking CXCR2 on Neutrophil Recruitment and Dextran Sodium Sulfate-Induced Colitis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.108.145862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}